DOCSLIB.ORG

Read PDF Edition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Read PDF Edition REVIEW OF OPTOMETRY EARN 2 CE CREDITS: Positive Visual Phenomena—Etiologies Beyond the Eye, PAGE 58 ■ VOL. 155 NO. 1 January 15, 2018 www.reviewofoptometry.comwww.reviewofoptometry.com ■ ANNUAL CORNEA REPORT JANUARY 15, 2018 ■ CXL ■ EPITHELIAL DEFECTS How to Heal Persistent Epithelial Defects PAGE 38 ■ TRANSPLANTS Corneal Transplants: The OD’s Role PAGE 44 ■ INFILTRATES Diagnosing Corneal Infiltrative Disease PAGE 50 ■ POSITIVE VISUAL PHENOMENA CXL: Your Top 12 Questions —Answered! PAGE 30 001_ro0118_fc.indd 1 1/5/18 4:34 PM ĊčĞĉėĆęĊĉĆĒēĎĔęĎĈĒĊĒćėĆēĊċĔėĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊĘ ĊđĎĊċĎēĘĎČčę ċċĊĈęĎěĊ Ȉ 1 Ȉ 1 ĊđđǦęĔđĊėĆęĊĉ Ȉ Ȉ ĎĒĕđĊĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊ Ȉ Ȉ ĔēěĊēĎĊēę Ȉ͝ Ȉ Ȉ Ƭ 1 ǡ ǡǡǤ͚͙͘͜Ǥ Ȁ Ǥ ͚͙͘͜ǣ͘͘ǣ͘͘͘Ǧ͘͘͘ ĕĕđĎĈĆęĎĔēĘ Ȉ Ȉ Ȉ Ȉ Ȉ čĊĚėĎĔē̾ėĔĈĊĘĘ Ȉ Ȉ Katena — Your completecomplete resource forfor amniotic membrane pprocedurerocedure pproducts:roducts: Single use speculums Single use spears ͙͘͘ǡ͘͘͘ήĊĞĊĘęėĊĆęĊĉ Forceps ® ,#"EWB3FW XXXLBUFOBDPNr RO0118_Katena.indd 1 1/2/18 10:34 AM News Review VOL. 155 NO. 1 ■ JANUARY 15, 2018 IN THE NEWS Accelerated CXL Shows The FDA recently approved Luxturna (voretigene neparvovec-rzyl, Spark Promise—and Caution Therapeutics), a directly administered gene therapy that targets biallelic This new technology is already advancing, but not without RPE65 mutation-associated retinal dystrophy. The therapy is designed to some bumps in the road. deliver a normal copy of the gene to By Rebecca Hepp, Managing Editor retinal cells to restore vision loss. While the approval provides hope for patients, wo new studies highlight the resulted in infection—while tradi- the $425,000 per eye price tag stands as pros and cons of accelerated tional C-CXL has a reported inci- a signifi cant hurdle. Tcorneal crosslinking (A- dence of 0.0017%.2 The researchers Scutti S. Gene therapy for rare retinal disorder to cost CXL). Researchers in Switzerland examined possible contributory fac- $425,000 per eye. CNN. www.cnn.com/2018/01/03/ health/luxturna-price-blindness-drug-bn/index.html. studied the outcomes of conven- tors in those seven cases and found Accessed January 4, 2018. tional (C-CXL) and accelerated young age, a pre-existing immuno- corneal crosslinking (A-CXL) in compromized state, poor hygiene A study 167 patients with suspected a pediatric population and found at the operation site and in post-op bacterial endophthalmitis after cataract A-CXL was equally effective after environments, long-term steroid surgery found intravitreal dexametha- one year.1 use and poor post-op education sone provided no improved visual “The potential advantages in- and management were all concerns. acuity. Patients were treated twice with clude reduced exposure time, better Although the study was limited to intravitreal injections of 0.2mg vanco- patient compliance and possibly one clinical site, it highlights the mycin and 0.05mg gentamicin, followed lower infection risk (more patient importance of patient education by either 400µg dexamethasone sodium and doctor friendly),” says S. Barry and careful post-op follow up with diphosphate or placebo. The four-week, Eiden, OD, president and medical this new procedure. 10-week, six-month and 12-month fol- director at North Suburban Vision These studies further highlight low ups showed no signifi cant difference Consultants, Ltd., and president not just the evolving nature of treat- in best-corrected visual acuity. and cofounder of the International ment, but “what we at the IKA call Manning S, Ugahary LC, Lindstedt EW, et al. A Keratoconus Academy (IKA). ‘the changing paradigm of kera- prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial en- The study included 78 eyes of toconus management,’” Dr. Eiden dophthalmitis after cataract surgery on the adjuvant use 58 pediatric patients with progres- says. With access to a treatment of intravitreal dexamethasone to intravitreal antibiotics. Acta Ophthalmol. December 7, 2017. [Epub]. sive keratoconus. Half of the eyes that can halt progression and pos- underwent C-CXL and half had A- sibly prevent vision loss, clinicians New research suggests a desktop CXL. One year post-procedure, the have a duty to diagnose patients humidifi er may help patients with researchers noted no difference in as early as possible and identify dry eye symptoms during continuous outcomes between the two groups, those at high risk of progression. computer use. Investigators measured including uncorrected visual acuity, Improved diagnostic technologies noninvasive tear break-up time (NTBUT) best-corrected visual acuity and would be welcome additions to the in patients who did and did not use a kmax values. The treatment failure evolving treatment options, such desktop humidifi er for an hour of com- rate was slightly lower for A-CXL, as A-CXL, for patients at risk for puter use and found improved NTBUT in at 15.4% compared with 23.1% of keratoconus, Dr. Eiden concludes. the humidifi er users compared with those the C-CXL group. 1. Baenninger PB, Bachmann LM, Wienecke L, et al. Pediatric without a humidifi er. However, a second study took corneal cross-linking: comparison of visual and topographic outcomes between conventional and accelerated treatment. Am Wang MT, Chan E, Ea L, et al. Randomized trial of a closer look at other A-CXL J Ophthalmol. 2017 Nov;183:11-16. desktop humidifi er for dry eye relief in computer users. outcomes such as infection rates 2. Maharana PK, Sahay P, Pranita, Sujeeth M, et al. Microbial Optom Vis Sci. 2017;94(11):1052-7. keratitis after accelerated corneal collagen cross-linking in and found 1.3% (seven of 532 eyes) keratoconus. Cornea. November 2, 2017. [Epub ahead of print]. REVIEW OF OPTOMETRY JANUARY 15, 2018 3 0003_ro0118_news(v2).indd03_ro0118_news(v2).indd 3 11/5/18/5/18 22:12:12 PPMM News Review Beware of ISNT Rule Exceptions, Study Says linicians who rely on the Photos: Jarett Mazzarella, OD ISNT rule when assessing Cthe optic nerve—for signs of early glaucoma, for example— should remember it doesn’t neces- sarily apply to all patients. While the rule states optic nerves typically show a larger rim width inferior, superior, nasal and then temporal, a new study highlights just how often patients deviate from this: within Optic nerves come in all shapes and sizes, making the ISNT rule tough to follow. Can this particular study population, you tell which are normal, anomalous but non-glaucomatous and glaucomatous? only 37.0% of rim assessments and 43.8% of retinal nerve fi ber layer most signifi cant causes of devia- for early signs of glaucoma, Dr. (RNFL) measurements follow the tion, with 10.9% of subjects having Mazzarella says the fi ndings serve rule, according to the researchers. a wider nasal rim than inferior, as a stark reminder of the impor- “As we know, there is a wide 29.4% with a wider nasal rim than tance of obtaining baseline readings, variance of normal nerve anatomy, superior, 14.7% with a narrower following for change over time and which makes diagnosing early glau- nasal rim than temporal and 42.9% “not getting stuck in the mindset of coma diffi cult in some patients,” having thinner nasal RNFLs com- always following traditional rules.” says Jarett Mazzarella, OD, who pared with the temporal quadrant. “Early disease is the confounding practices in the VA Health Care Sys- “We know glaucoma patients factor between identifying abnor- tem in Salisbury, NC. “Although a tend to lose neuroretinal rim on the mal structure vs. a normal variant. number of patients in the study did superior and inferior rims, and in For example, we see this often with not conform to the standard rule, this study, excluding the nasal rim our OCT technology when a patient in my opinion it does not invalidate to modify the rule to the IST or IS fl ags as abnormal on OCT RNFL the ISNT rule since the areas of made it apply to roughly 70%,” or ganglion cell compared with the rim we are concerned with in says Justin Cole, OD, of the VA the normative data values,” Dr. early glaucoma are the inferior or Health Care System in Salisbury, Mazzarella says. “Many of these superior rim.” NC. “So the rule still applies, but I patients never change or progress, Researchers looked at 110 nor- also think we have really been using which usually indicates a variant mal subjects and found a larger or it as the ‘IS’ rule all along.” of normal anatomy. It comes down smaller nasal sector was one of the For clinicians assessing patients to establishing a baseline for that individual patient and watching Hot Tea’s Impact on Glaucoma for any indication of structural or Tea drinkers have one more reason to brew another pot this functional progression over time, winter. A new study found drinking hot, caffeinated tea may especially for the normal nerve that be associated with a lower risk of glaucoma. Data from the does not look so ‘typical.’” 2005-2006 National Health and Nutrition Examination Survey “Each clinician must use their indicates hot tea-drinkers were 74% less likely to have own judgment in identifying normal glaucoma. The same was not true for coffee (caffeinated or from abnormal cup-to-disc ratios decaffeinated) decaffeinated tea, iced tea or soft drinks. and appearances, while also having While the survey had a small number of patients diagnosed with glaucoma and didn’t take the wherewithal to know that ana- into account other factors such as cup size, tea type or brewing time, the researchers speculate tomical differences are common,” the tea’s antioxidants and anti-infl ammatory and neuroprotective chemicals may play a role. concludes Dr. Cole. Poon LYC, Valle DSD, Turalba AV, et al. The ISNT rule: how often Wu CM, Wu AM, Tseng VL, et al. Frequency of a diagnosis of glaucoma in individuals who consume coffee, tea and/or soft does it apply to disc photographs and retinal nerve fi ber layer drinks.
Load more

Recommended publications
  • Customer Vision Report (MED 4)
    MED 4 (11/25/2020) CUSTOMER VISION REPORT Purpose: Use this form to request vision examination information from your ophthalmologist or optometrist. Instructions: Complete the Customer Information section and have your Ophthalmologist/Optometrist complete the Vision Examination section. The vision examination must be conducted within 90 days prior to submission of the report to DMV. Mail the completed report to the address above. Questions can be referred to Medical Review Services, 804-367-6203. Acceptable standards of vision for safe driving are determined by the Code of Virginia and DMV under the guidance of the Medical Advisory Board. Note: Any charges incurred for the completion of this form are your responsibility. CSC STAFF Do NOT send MED 4 back with daily work unless there is an ocular condition or customer cannot be licensed due to a MED 6 calculation. CUSTOMER INFORMATION (To be completed by customer PRIOR to vision examination) If you change either your residence/home address or mailing address to a non-Virgina address, your driver license or photo identification (ID) card may be cancelled. NAME (last) (first) (mi) (suffix) CUSTOMER NUMBER (from your driver license) or SSN RESIDENCE/HOME ADDRESS BIRTHDATE (mm/dd/yyyy) CITY STATE ZIP CODE CITY OR COUNTY OF RESIDENCE MAILING ADDRESS (if different from above) CITY STATE ZIP CODE DAYTIME TELEPHONE NUMBER VISION EXAMINATION (to be completed by Ophthalmologist/Optometrist) FIRST EXAMINATION DATE MOST RECENT EXAMINATION DATE Does the patient have any visual/ocular condition(s) that could affect the ability to drive a motor vehicle? YES NO If YES, indicate condition below.
    [Show full text]
  • 214622Orig1s000
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 214622Orig1s000 MULTI-DISCIPLINE REVIEW Summary Review Office Director Cross Discipline Team Leader Review Clinical Review Non-Clinical Review Statistical Review Clinical Pharmacology Review NDA214622 Multi‐disciplinary Review and Evaluation Infigratinib (Truseltiq) NDA/BLA Multi‐disciplinary Review and Evaluation FDA review was conducted in conjunction with other regulatory authorities under a regular ORBIS. While the application review is completed by the FDA, the application is still under review at the other regulatory agencies (Health Canada and Therapeutic Goods Administration). Disclaimer: In this document, the sections labeled as “Data” and “The Applicant’s Position” are completed by the Applicant, which do not necessarily reflect the positions of the FDA. Application Type NDA Application Number(s) 214622 Priority or Standard Priority Submit Date(s) September 29, 2020 Received Date(s) September 29, 2020 PDUFA Goal Date May 29, 2021 Division/Office OOD/DO3 Review Completion Date Please check electronic date stamp Established Name Infigratinib Trade Name Truseltiq Pharmacologic Class FGFR Inhibitor Code name BGJ398 Applicant QED Therapeutics, Inc. Formulation(s) Oral capsule Dosing Regimen 125 mg orally once daily for 21 consecutive days followed by 7 days off therapy, in 28‐day cycles Applicant Proposed The treatment of adult patients with previously treated, Indication(s)/Population(s) unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 gene fusions or other rearrangement as detected by an FDA approved test. Recommendation on Approval Regulatory Action Recommended For the treatment of adults with previously treated, Indication(s)/Population(s) unresectable locally advanced or metastatic (if applicable) cholangiocarcinoma with an FGFR2 fusion or other rearrangement as detected by an FDA‐approved test.
    [Show full text]
  • KITS: Good Growth, Solid Unit Economics, Aligned Management
    Matt Koranda, (949) 720-7119 [email protected] Gustavo Gala, (949) 720-7116 [email protected] Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE | EQUITY RESEARCH | February 16, 2021 Consumer: DTC & Disruptors Initiation of Coverage Kits Eyecare Ltd. | KITS.TO - C$8.13 - TSX | Buy Stock Data 52-Week Low - High C$7.55 - C$10.20 KITS: Good Growth, Solid Unit Economics, Shares Out. (mil) 31.00 Aligned Management; Initiate at Buy Mkt. Cap.(mil) C$252.03 3-Mo. Avg. Vol. NA With its digital-first approach to selling contacts and prescription glasses/ 12-Mo.Price Target C$13.00 sunglasses, we see a long runway of growth ahead as Kits capitalizes on a Cash (mil) C$43.2 steady shift of the USD $35bn North American eyewear market into online Tot. Debt (mil) C$11.0 channels (only 13% sold online in 2021, under-penetrated vs. most consumer Revenue (C$ millions) categories). We like Kits' dual-pronged strategy of converting customers into high-visibility auto-ship programs while driving glasses growth, as these Yr Dec —2020— —2021E— —2022E— improve customer-level profitability. Moreover, management has a track- Curr Curr 1Q NA 22.5E 32.4E record of success and owns ~70% of shares. 2Q NA 32.1E 45.3E ■ 3Q 20.2A 31.8E 44.9E We initiate coverage on Kits Eyecare at Buy with a $13 PT. Kits 4Q 19.6A 30.6E 41.2E offers vision testing, prescription renewals, and products such as contact YEAR 74.5A 116.9E 163.9E lenses and eyeglasses through its website, kits.com.
    [Show full text]
  • Update on Pathologic Diagnosis of Corneal Infections and Inflammations
    [Downloaded free from http://www.meajo.org on Tuesday, March 27, 2012, IP: 41.234.93.234] || Click here to download free Android application for this journal Eye Pathology Update Update on Pathologic Diagnosis of Corneal Infections and Inflammations Geeta K. Vemuganti, Somasheila I. Murthy1, Sujata Das2 ABSTRACT Access this article online Website: One of the most frequent types of corneal specimen that we received in our pathology laboratory www.meajo.org is an excised corneal tissue following keratoplasty. Several of these cases are due to corneal DOI: infections or the sequelae, like corneal scar. Advances in the histological and molecular 10.4103/0974-9233.90128 diagnosis of corneal infections and inflammations have resulted in rapid and accurate diagnosis Quick Response Code: of the infectious agent and in the overall understanding of the mechanisms in inflammatory diseases of the cornea. This review provides an update of histopathological findings in various corneal infections and inflammations. Key words: Corneal Histopathology, Corneal Infiltrate, Corneal Inflammations, Microbial Keratitis, Moorens’ Ulcer INTRODUCTION Corneal infections often commence as epithelial ulceration followed by stromal infiltration by polymorphonuclear (PMN) eratitis is an important cause of ocular morbidity worldwide, and lymphomononuclear cells leading to destruction of Bowman’s Kthe outcome of which depends on early diagnosis, prompt layer, stromal necrosis and perforation of the Descemet’s 1 and effective treatment and various host and agent factors. Some membrane in severe cases. Suppurative infections like bacterial of the common causes of infectious keratitis include bacterial, and fungal lead to infiltrates in anterior 2/3 of stroma and abscess fungal, viral, and protozoan, the diagnosis of which is made on formation.
    [Show full text]
  • A Large Vision Network Means There's Always a Provider In
    Vision Plans Network Options A large vision network means there’s always a provider in sight. UnitedHealthcare knows how important it is to find a provider you can trust who meets your lifestyle, eye care and eyewear needs. With our large national eye care network, Spectera Eyecare Networks, you can choose to get more personalized care from a private practice. Or, take advantage of the convenience retail chains offer with evening and weekend hours. Either way, we’re focused on providing you with a better eye care experience. Well-known practices and brands in our large national network include: • 20/20 Vision Center • Eye Boutique • 3 Guys Optical • EyeCare Associates • AccurateOptical • Eye Express • All About Eyes • eyecarecenter Making it easier for you • Allegany Eyecare • Eyeglass World to find a provider. • America’s Best • EyeMart Express To find the provider who best • Bard Optical • Eyetique meets your needs, login to • BJ’s Optical • For Eyes myuhcvision.com or call • Boscov’s Optical • General Vision Services 1-800-638-3120. • Clarkson Eyecare • H. Rubin Vision Centers Some providers or locations may not participate in your plan. • Co/Op Optical • Henry Ford OptimEyes • Cohen’s Fashion Optical • Horizon Eye Care • Costco Optical • Houston Eye Associates • Crown Vision Center • JC Penney Optical • Dr. Travel Family Eye Care • Midwest Vision Centers CONTINUED • MyEyeDr. • Standard Optical • National Optometry • Stanton Optical • National Vision • Sterling Optical • Nationwide Vision • SVS Vision • NUCROWN • Target Optical (not available for • Optical Shop at Meijer all members) • Optyx • Texas State Optical • Ossip Optometry • The Eye Gallery • Pearle Vision • The Hour Glass • Rosin Eyecare • Thoma & Sutton Optical • RX Optical • Today’s Vision • Sam’s Club • Virginia Eye Institute • Schaeffer Eye Centers • Vision4Less • Sears Optical (not available for • Visionmart Express all members) • Visionworks • See Inc.
    [Show full text]
  • Boosting Learning Efficacy with Non-Invasive Brain Stimulation in Intact and Brain-Damaged Humans
    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Behavioral/Cognitive Boosting learning efficacy with non-invasive brain stimulation in intact and brain-damaged humans F. Herpich1,2,3, F. Melnick, M.D.4 , S. Agosta1 , K.R. Huxlin4 , D. Tadin4 and L Battelli1,5,6 1Center for Neuroscience and Cognitive Systems@UniTn, Istituto Italiano di Tecnologia, Corso Bettini 31, 38068 Rovereto (TN), Italy 2Center for Mind/Brain Sciences, University of Trento, 38068 Rovereto, Italy 3kbo Klinikum-Inn-Salzach, Gabersee 7, 83512, Wasserburg am Inn, Germany 4Department of Brain and Cognitive Sciences, Flaum Eye Institute and Center for Visual Science, University of Rochester, Rochester, NY, USA 5Berenson-Allen Center for Noninvasive Brain Stimulation and Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215 Massachusetts, USA 6Cognitive Neuropsychology Laboratory, Harvard University, Cambridge, MA, USA https://doi.org/10.1523/JNEUROSCI.3248-18.2019 Received: 28 December 2018 Revised: 10 April 2019 Accepted: 8 May 2019 Published: 27 May 2019 Author contributions: F.H., M.D.M., K.H., D.T., and L.B. designed research; F.H., M.D.M., and S.A. performed research; F.H., M.D.M., and D.T. analyzed data; F.H., M.D.M., and L.B. wrote the first draft of the paper; M.D.M., S.A., K.H., D.T., and L.B. edited the paper; K.H., D.T., and L.B. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. The present study was funded by the Autonomous Province of Trento, Call “Grandi Progetti 2012”, project “Characterizing and improving brain mechanisms of attention — ATTEND (FH, SA, LB), “Fondazione Caritro — Bando Ricerca e Sviluppo Economico” (FH), NIH (DT, MM and KRH: R01 grants EY027314 and EY021209, CVS training grant T32 EY007125), and by an unrestricted grant from the Research to Prevent Blindness (RPB) Foundation to the Flaum Eye Institute.
    [Show full text]
  • Migraine Triggered Seizures and Epilepsy Triggered Headache and Migraine Attacks: a Need for Re-Assessment
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central J Headache Pain (2011) 12:287–288 DOI 10.1007/s10194-011-0344-2 COMMENTARY Migraine triggered seizures and epilepsy triggered headache and migraine attacks: a need for re-assessment Paul T. G. Davies • C. P. Panayiotopoulos Received: 5 April 2011 / Accepted: 8 April 2011 / Published online: 24 April 2011 Ó The Author(s) 2011. This article is published with open access at Springerlink.com In this issue of the Journal, Belcastro and associates review Migralepsy terminology and classification issues for migralepsy, hem- icrania epileptica, post-ictal and ictal headache [1]. They According to the ICHD-II 1.5.5, ‘‘migraine-triggered sei- raise key points such as ictal headache and visual seizures zure (sometimes referred to as migralepsy)’’ denotes an are often misdiagnosed as migraine, ‘‘migralepsy’’ is unli- epileptic seizure that occurs ‘‘during or within one hour kely to exist and an ‘‘epilepsy-migraine sequence’’ is much after a migraine aura’’ [3]. However, the evidence of this more common and well documented than the dominant ‘‘migraine-seizure’’ sequence is weak and the proposed view of a ‘‘migraine-epilepsy sequence’’. Their relevant criterion of 1 h gap between the end of the ‘‘aura’’ and the proposals need appropriate attention by the committee of start of an epileptic seizure is entirely arbitrary the international classification of headache disorders Migralepsy is an old term derived from migra(ine) and (ICHD) as well as the physicians in their clinical practice (epi)lepsy, coined by Dr Douglas Davidson, but mainly because of the consequences that misdiagnosis may have on attributed to Lennox and Lennox, which we quote, ‘‘a patients.
    [Show full text]
  • Mechanisms Compensating for Visual Field Restriction in Adolescents With
    Eye (2012) 26, 1437–1445 & 2012 Macmillan Publishers Limited All rights reserved 0950-222X/12 www.nature.com/eye 1;2 3;4 1 Mechanisms L Jacobson , F Lennartsson , T Pansell ,GO¨ qvist CLINICAL STUDY Seimyr2 and L Martin2;5 compensating for visual field restriction in adolescents with damage to the retro-geniculate visual system 1Eye Unit, Department of Neuropaediatrics, Astrid Lindgren Children’s Hospital, Karolinska University Abstract Hospital, Stockholm, Background To describe visual field (VF) Conclusion Congenital and later-acquired Sweden outcome in three adolescents with damage to homonymous VF defects may, at least in 2 the optic radiation and to focus on young subjects, be compensated for by Department of Clinical Neuroscience, mechanisms that may compensate the scanning. Exotropia may compensate VF Ophthalmology and Vision, practical functional limitations of VF defects. defects and, therefore, the VF should be Karolinska Institutet, Design Descriptive, prospective multi-case tested before strabismus surgery. Stockholm, Sweden study in a hospital setting. Eye (2012) 26, 1437–1445; doi:10.1038/eye.2012.190; Participants Three teenagers with cerebral published online 21 September 2012 3Department of Medical visual dysfunction because of damage to the Physics, Karolinska University Hospital, retro-geniculate visual pathways. Keywords: VF defects; retro-geniculate visual Stockholm, Sweden Methods Best-corrected visual acuity and system; compensating mechanisms; eye alignment were assessed. Visual field adolescents 4Department of function was tested with Goldmann Neuroradiology, Karolinska perimetry, and with Rarebit, Humphrey University Hospital, Introduction Visual Field Analyzer and Esterman Stockholm, Sweden computerized techniques. Fixation was Brain damage has become the most common 5School of Health and registered with video oculography during cause of visual impairment in children in Welfare, Ma¨ lardalen 1–3 Rarebit examination.
    [Show full text]
  • Neuro-Ophthalmic Side Effects of Molecularly Targeted Cancer Drugs
    Eye (2018) 32, 287–301 © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 0950-222X/18 www.nature.com/eye 1,2,3 4 Neuro-ophthalmic side MT Bhatti and AKS Salama REVIEW effects of molecularly targeted cancer drugs Abstract The past two decades has been an amazing time culminated in indescribable violence and in the advancement of cancer treatment. Mole- unspeakable death. However, amazingly within cularly targeted therapy is a concept in which the confines of war have risen some of the specific cellular molecules (overexpressed, greatest advancements in medicine. It is within mutationally activated, or selectively expressed this setting—in particular World War II with the proteins) are manipulated in an advantageous study of mustard gas—that the annals of cancer manner to decrease the transformation, prolif- chemotherapy began touching the lives of eration, and/or survival of cancer cells. In millions of people. It is estimated that in 2016, addition, increased knowledge of the role of the over 1.6 million people in the United States will immune system in carcinogenesis has led to the be diagnosed with cancer and over a half a development of immune checkpoint inhibitors million will die.1 The amount of money being to restore and enhance cellular-mediated anti- spent on research and development of new tumor immunity. The United States Food and cancer therapies is staggering with a record $43 Drug Administration approval of the chimeric billion dollars spent in 2014. Nearly 30% of all monoclonal antibody (mAb) rituximab in 1997 registered clinical trials on the clinicaltrials.gov 1Department of for the treatment of B cell non-Hodgkin lym- website pertain to cancer drugs.
    [Show full text]
  • Elementary Visual Hallucinations, Blindness, and Headache in Idiopathic Occipital Epilepsy: Diverentiation from Migraine
    536 J Neurol Neurosurg Psychiatry 1999;66:536–540 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.66.4.536 on 1 April 1999. Downloaded from SHORT REPORT Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: diVerentiation from migraine C P Panayiotopoulos Abstract also fundamental symptoms often with the This is a qualitative and chronological same sequence of events in occipital seizures.1−9 analysis of ictal and postictal symptoms, This is a systematic prospective qualitative frequency of seizures, family history, study of the characteristics of elementary visual response to treatment, and prognosis in hallucinations, blindness, and headache in nine patients with idiopathic occipital epi- idiopathic occipital epilepsy. lepsy and visual seizures. Ictal elementary visual hallucinations are stereotyped for Methods each patient, usually lasting for seconds. These are detailed elsewhere.910 Patients with They consist of mainly multiple, bright occipital seizures were prospectively evaluated coloured, small circular spots, circles, or and followed up from 1973. Nine patients with balls. Mostly, they appear in a temporal idiopathic occipital epilepsy with visual halluci- hemifield often moving contralaterally or nations (IOEVH) had: in the centre where they may be flashing. (a) Incontrovertible clinical evidence of oc- They may multiply and increase in size in cipital seizures with or without secondarily the course of the seizure and may progress generalisation. to other non-visual occipital seizure (b) Normal physical, neurological, and men- symptoms and more rarely to extra- tal states and high resolution MRI. They all had detailed interviews, seven com- occipital manifestations and convulsions. 9 Blindness occurs usually from the begin- pleted a purposely designed questionnaire, ning and postictal headache, often indis- and eight provided drawings of their visual hal- tinguishable from migraine, is common.
    [Show full text]
  • Case 1:21-Cv-06966 Document 1 Filed 08/18/21 Page 1 of 38
    Case 1:21-cv-06966 Document 1 Filed 08/18/21 Page 1 of 38 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK 1-800 CONTACTS, INC. ) ) Plaintiff, ) ) v. ) Case No. ________________ ) JAND, INC. d/b/a WARBY PARKER ) ) Jury Trial Demanded Defendant. ) COMPLAINT Plaintiff 1-800 Contacts, Inc. (“1-800 Contacts”) makes the following allegations in support of its Complaint against Defendant JAND, Inc., d/b/a Warby Parker (“Warby Parker”): NATURE OF THE ACTION 1. This is an action to stop and remedy Defendant Warby Parker’s continuing trademark infringement, unfair competition, and deceptive advertising practices. Plaintiff 1-800 Contacts is a well-known pioneer in the online contact lens marketplace. Over the past three decades, 1-800 Contacts has expended hundreds of millions of dollars on advertising, marketing, and promotion to cultivate strong consumer recognition of its brand, services, and trademarks. 2. 1-800 Contacts’ investments and decades-long commitment to its customers has paid off, as the company now serves millions of customers. Indeed, between June 1, 2020, and June 30, 2021, alone, the 1800contacts.com website averaged more than 1.5 million unique visitors monthly. Case 1:21-cv-06966 Document 1 Filed 08/18/21 Page 2 of 38 3. 1-800 Contacts is an online—rather than a brick-and-mortar—retailer, so millions of customers and prospective customers reach 1-800 Contacts by navigating to the 1800contacts.com website. In an effort to navigate to its online store at the 1800contacts.com website, many consumers type “1800 Contacts,” “1 800 Contacts,” “1800contacts.com,” “1800contacts,” or other of 1-800 Contacts’ trademarks as search terms in search engines such as Google.
    [Show full text]
  • Anterior Segment Surgery and Complications CATARACT EXTRACTION and INTRAOCULAR LENS IMPLANTATION
    10 Anterior Segment Surgery and Complications CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION Complications PENETRATING KERATOPLASTY Complications Correction of Astigmatism in a Corneal Graft LAMELLAR KERATOPLASTY SUPERFICIAL KERATECTOMY EXCIMER LASER PHOTOTHERAPEUTIC KERATECTOMY CONJUNCTIVAL FLAP LIMBAL STEM CELL TRANSPLANTATION PTERYGIUM EXCISION AND CONJUNCTIVAL AUTOGRAFT CONJUNCTIVAL AND CORNEAL TUMOR EXCISION CORNEAL PERFORATION SURGERY PERMANENT KERATOPROSTHESIS REFRACTIVE SURGERY Radial Keratotomy Excimer Laser Photorefractive Keratectomy Laser In Situ Keratomileusis CONCLUSION Anterior segment surgery ranges from routine cataract extraction and lens implantation, one of the most common surgical operations in the United States, to rarely performed surgery such as permanent keratoprosthesis. It also encompasses surgery first performed centuries ago, such as rudimentary pterygium excision, to the latest in keratorefractive surgery. CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION The many reasons for the development of cataracts are discussed in detail in Chapter 8. Most cataracts are acquired, but they can also be congenital. This section focuses primarily on the treatment of acquired cataracts in adults. Cataracts in adults are generally age related, but some lens opacities may result from other causes such as trauma, inflammation, systemic illness such as diabetes, or medications such as corticosteroids. Cataracts generally advance slowly over years but can advance rapidly over months, or even faster in some patients. The primary indication for cataract extraction is diminished vision caused by the cataract, significantly affecting the patient's lifestyle. The exact point at which this hardship occurs depends on the patient. Certain patients require little visual function and may delay cataract surgery for years or indefinitely. Other patients with high visual needs seek cataract surgery with much smaller degrees of visual loss.
    [Show full text]